CRIF1 Interacting with CDK2 Regulates Bone Marrow Microenvironment-Induced G0/G1 Arrest of Leukemia Cells

To assess the level of CR6-interacting factor 1 (CRIF1), a cell cycle negative regulator, in patients with leukemia and investigate the role of CRIF1 in regulating leukemia cell cycle. We compared the CRIF1 level in bone marrow (BM) samples from healthy and acute myeloid leukemia (AML), iron deficie...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 9; no. 2; p. e85328
Main Authors Ran, Qian, Hao, Ping, Xiao, Yanni, Xiang, Lixing, Ye, Xingde, Deng, Xiaojun, Zhao, Jiang, Li, Zhongjun
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 10.02.2014
Public Library of Science (PLoS)
Subjects
Online AccessGet full text
ISSN1932-6203
1932-6203
DOI10.1371/journal.pone.0085328

Cover

More Information
Summary:To assess the level of CR6-interacting factor 1 (CRIF1), a cell cycle negative regulator, in patients with leukemia and investigate the role of CRIF1 in regulating leukemia cell cycle. We compared the CRIF1 level in bone marrow (BM) samples from healthy and acute myeloid leukemia (AML), iron deficiency anemia (IDA) and AML-complete remission (AML-CR) subjects. We also manipulated CRIF1 level in the Jurkat cells using lentivirus-mediated overexpression or siRNA-mediated depletion. Co-culture with the BM stromal cells (BMSCs) was used to induce leukemia cell cycle arrest and mimic the BM microenvironment. We found significant decreases of CRIF1 mRNA and protein in the AML group. CRIF1 overexpression increased the proportion of Jurkat cells arrested in G0/G1, while depletion of endogenous CRIF1 decreased cell cycle arrest. Depletion of CRIF1 reversed BMSCs induced cell cycle arrest in leukemia cells. Co-immunoprecipitation showed a specific binding of CDK2 to CRIF1 in Jurkat cells during cell cycle arrest. Co-localization of two proteins in both nucleus and cytoplasm was also observed with immunofluorescent staining. CRIF1 may play a regulatory role in the BM microenvironment-induced leukemia cell cycle arrest possibly through interacting with CDK2 and acting as a cyclin-dependent kinase inhibitor.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Competing Interests: The authors have declared that no competing interests exist.
Conceived and designed the experiments: ZL. Wrote the manuscript: ZL. Regulated Crif1 expression and detected Crif1 location and interaction with CDK2: QR. Collected clinical samples and analyzed the expression level of Crif1 in these samples: PH. Isolated and expanded BMSCs: YX. Cultured and co-cultured cells: LX. Detected the effect of Crif1 on cell cycle: XY. Gathered and analyzed confocal images: XD. Analyzed statistics: JZ.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0085328